Since the first report in 2014 linking biallelic mutations of EIF2AK4 to PVOD [8], approximately one hundred EIF2AK4 alleles have been reported to be associated with PAH and its subtypes [4, 8–14]. The gene discussed is EIF2AK4; the disease is pulmonary arterial hypertension.